community download

Biomarker Development: CENTOGENE’s approach for rare diseases

Developing adequate therapeutic options for patients affected by rare genetic disease is challenging. In addressing these challenges, a deeper understanding of the conditions beyond the levels of phenotype and genotype is crucial. This paper describes CENTOGENE’s unique data repository and how it provides not only expert understanding of rare diseases, but also enables the company to rapidly develop metabolomic-/proteomic-based biomarkers. These functional markers can facilitate patients’ diagnoses, accelerate drug development, and improve monitoring - leading to improved outcomes for patients and their care-givers.

Some quick details

Email Address:*
First name:*
Last name:*
Job Title:*
Company:*
Industry:
Country:*

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details


Privacy statement »
Manage your email preferences »
 

You will be emailed the document as an attachment (736Kb in size)